These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31938592)

  • 21. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
    Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
    World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
    Kwaan MR; Fan Y; Jarosek S; Elliott SP
    Dis Colon Rectum; 2017 Jul; 60(7):682-690. PubMed ID: 28594717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are survival rates different for young and older patients with rectal cancer?
    O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
    Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
    Modrek AS; Hsu HC; Leichman CG; Du KL
    Radiat Oncol; 2015 Apr; 10():101. PubMed ID: 25902707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of preoperative radiotherapy in stage II and III rectal cancer patients: A Strobe-compliant study of SEER 18 registries database (1988-2011).
    Wang R; Zhao D; Liu YJ; Ye C; Qian JR; Dai JN; Liu SY; Liu JY; Li B; Wang MJ; Ping J
    Neoplasma; 2019 Nov; 66(6):995-1001. PubMed ID: 31305123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma.
    Lee W; Nelson R; Akmal Y; Mailey B; McKenzie S; Artinyan A; Ashing-Giwa KT; Chen YJ; Garcia-Aguilar J; Kim J
    Int J Colorectal Dis; 2012 Jun; 27(6):737-49. PubMed ID: 22159751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.
    Neugut AI; Fleischauer AT; Sundararajan V; Mitra N; Heitjan DF; Jacobson JS; Grann VR
    J Clin Oncol; 2002 Jun; 20(11):2643-50. PubMed ID: 12039925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
    Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
    World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors.
    Mahmood U; Koshy M; Goloubeva O; Suntharalingam M
    Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1025-30. PubMed ID: 22006781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
    Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.